DK1017822T3 - LKTA-deletionsmutant af P. haemolytica - Google Patents
LKTA-deletionsmutant af P. haemolyticaInfo
- Publication number
- DK1017822T3 DK1017822T3 DK98949510T DK98949510T DK1017822T3 DK 1017822 T3 DK1017822 T3 DK 1017822T3 DK 98949510 T DK98949510 T DK 98949510T DK 98949510 T DK98949510 T DK 98949510T DK 1017822 T3 DK1017822 T3 DK 1017822T3
- Authority
- DK
- Denmark
- Prior art keywords
- haemolytica
- lkta
- deletion mutant
- mutants
- ruminants
- Prior art date
Links
- 241001293418 Mannheimia haemolytica Species 0.000 title abstract 2
- 230000037430 deletion Effects 0.000 title 1
- 238000012217 deletion Methods 0.000 title 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241000283707 Capra Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 208000008939 Pneumonic Pasteurellosis Diseases 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6006097P | 1997-09-25 | 1997-09-25 | |
| PCT/US1998/020097 WO1999015670A1 (en) | 1997-09-25 | 1998-09-25 | LKTA DELETION MUTANT OF $i(P. HAEMOLYTICA) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1017822T3 true DK1017822T3 (da) | 2007-03-12 |
Family
ID=22027061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98949510T DK1017822T3 (da) | 1997-09-25 | 1998-09-25 | LKTA-deletionsmutant af P. haemolytica |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6331303B1 (da) |
| EP (1) | EP1017822B1 (da) |
| AT (1) | ATE344326T1 (da) |
| AU (1) | AU743654B2 (da) |
| CA (1) | CA2303390C (da) |
| DE (1) | DE69836341T2 (da) |
| DK (1) | DK1017822T3 (da) |
| ES (1) | ES2279582T3 (da) |
| NZ (2) | NZ503463A (da) |
| PT (1) | PT1017822E (da) |
| WO (1) | WO1999015670A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6793927B1 (en) | 1993-12-06 | 2004-09-21 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
| CA2394357C (en) | 1999-12-17 | 2014-04-22 | University Of Guelph | Modified leukotoxin gene and protein |
| US20020058265A1 (en) * | 2000-09-15 | 2002-05-16 | Promega Corporation | Detection of microsatellite instability and its use in diagnosis of tumors |
| US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| US9370561B2 (en) | 2012-11-08 | 2016-06-21 | Merial, Inc. | Attenuated mannheimia haemolytica vaccines and methods of making and use |
| US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
| US9480739B2 (en) | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
| AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
| TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| WO2016034610A1 (en) | 2014-09-03 | 2016-03-10 | Intervet International B.V. | Attenuated bovine coronavirus and related vaccines |
| NL2018155B1 (en) | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
| US11679150B2 (en) * | 2020-03-03 | 2023-06-20 | The United States Of America, As Represented By The Secretary Of Agriculture | Mycoplasma bovis vaccine product |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422110A (en) * | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
| US5587305A (en) * | 1993-12-06 | 1996-12-24 | The United States Of America As Represented By The Department Of Agriculture | Pasteurella haemolytica transformants |
| AUPN631395A0 (en) * | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(II) |
| US5840556A (en) * | 1996-05-08 | 1998-11-24 | The United States Of America As Represented By The Department Of Agriculture | Molecular genetic construction of vaccine strains of pasteurellaceae |
-
1998
- 1998-09-25 NZ NZ503463A patent/NZ503463A/xx not_active IP Right Cessation
- 1998-09-25 ES ES98949510T patent/ES2279582T3/es not_active Expired - Lifetime
- 1998-09-25 DK DK98949510T patent/DK1017822T3/da active
- 1998-09-25 PT PT98949510T patent/PT1017822E/pt unknown
- 1998-09-25 NZ NZ514103A patent/NZ514103A/xx not_active IP Right Cessation
- 1998-09-25 AT AT98949510T patent/ATE344326T1/de not_active IP Right Cessation
- 1998-09-25 DE DE69836341T patent/DE69836341T2/de not_active Expired - Lifetime
- 1998-09-25 WO PCT/US1998/020097 patent/WO1999015670A1/en active IP Right Grant
- 1998-09-25 US US09/160,340 patent/US6331303B1/en not_active Expired - Lifetime
- 1998-09-25 AU AU95817/98A patent/AU743654B2/en not_active Expired
- 1998-09-25 EP EP98949510A patent/EP1017822B1/en not_active Expired - Lifetime
- 1998-09-25 CA CA2303390A patent/CA2303390C/en not_active Expired - Lifetime
-
2001
- 2001-10-19 US US09/982,232 patent/US6495145B2/en not_active Expired - Lifetime
- 2001-10-19 US US09/981,897 patent/US6573093B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2303390A1 (en) | 1999-04-01 |
| US6331303B1 (en) | 2001-12-18 |
| AU9581798A (en) | 1999-04-12 |
| NZ514103A (en) | 2001-09-28 |
| US6495145B2 (en) | 2002-12-17 |
| NZ503463A (en) | 2002-10-25 |
| DE69836341D1 (de) | 2006-12-14 |
| EP1017822B1 (en) | 2006-11-02 |
| US20020086413A1 (en) | 2002-07-04 |
| DE69836341T2 (de) | 2007-05-31 |
| US20020039589A1 (en) | 2002-04-04 |
| PT1017822E (pt) | 2007-02-28 |
| EP1017822A1 (en) | 2000-07-12 |
| ATE344326T1 (de) | 2006-11-15 |
| CA2303390C (en) | 2010-02-23 |
| WO1999015670A1 (en) | 1999-04-01 |
| ES2279582T3 (es) | 2007-08-16 |
| AU743654B2 (en) | 2002-01-31 |
| US6573093B2 (en) | 2003-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1017822T3 (da) | LKTA-deletionsmutant af P. haemolytica | |
| DE69330294T2 (de) | Inter-hierarchisches Synchronisationssystem und LSI, das dieses System verwendet | |
| FR11C0037I1 (da) | ||
| UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
| IT1158039B (it) | 2-/4-/(4,4-dialchil-2,6-piperidindion-1-il)-butil/1-piperazinil/pirimidine ad attivita' ansiolitica selettiva, procedimento per la loro preparazione e preparati farmaceutici che le contengono | |
| GB9416442D0 (en) | Therapeutic heterocycles | |
| ES2173170T3 (es) | Construccion de mutantes de pasteurella haemolytica. | |
| IT1141249B (it) | Procedimento per la preparazione di copolimeri di polisaccaridi supprotanti attivita' enzimatica,e copolimeri cosi' ottenuti | |
| NO904342D0 (no) | Fiskevaksine omfattende en virulent, inntrengende bakterie | |
| IT8120393A0 (it) | Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono. | |
| DE69635472D1 (de) | Impfstoff gegen Geflügelkokzidose | |
| FR2748476B1 (fr) | Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant | |
| NZ330050A (en) | Detection, prevention and treatment of papillomatus digital dermatitis in ruminants using biologically pure Serpens spp | |
| GB9810084D0 (en) | Proteins | |
| DE3879492T2 (de) | Hexafluoroneopentyl alkohol, dessen derivate, fluorierte polymere und deren verwendung. | |
| ES469908A1 (es) | Procedimiento de utilizacion de salinomicina. | |
| DE10199019I1 (de) | Impfstoff zum Schutz gegen Schweinhaemophilus | |
| NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
| Kirven | Studies of role of predominant rumen bacteria in the etiology of polioencephalomalacia | |
| Klumpenhouwer | Sets, operators and voice leading in Anton Webern's opus 12/i | |
| MX9604262A (es) | Antigenos de pasteurellaceae y vacunas relacionadas. | |
| IT8504242V0 (it) | Iniettore per la fecondazione artificiale in particolare per suini. | |
| DK240290D0 (da) | Fiskevaccine omfattende en virulent, invasiv bakterie | |
| GB9824569D0 (en) | Virulence gene and protein,and their use | |
| GB9824570D0 (en) | Virulence gene and protein,and their use |